News Focus
News Focus
icon url

dewophile

05/24/16 11:08 AM

#201551 RE: DewDiligence #201546

olaratumab looks like the real deal - HR .4 in sarcoma in phase 2
If I recall you thought LLY overpaid for imclone, but this could end up being a significant asset from that purchase